Doral

How Does Doral (Quazepam) Work?

Quazepam works by binding to stereospecific sites on GABA-A receptors in the central nervous system. This binding amplifies the inhibitory effects of GABA (gamma-aminobutyric acid), the brain's primary calming neurotransmitter. When GABA is enhanced, neuronal activity is reduced, producing sedation, hypnosis, and anxiolysis. Quazepam is notably selective for type 1 (omega-1) benzodiazepine receptors, which are associated primarily with hypnotic and anticonvulsant effects, rather than the anxiolytic and muscle-relaxant effects mediated by type 2 receptors.

Quazepam is rapidly absorbed with a peak plasma concentration occurring approximately 2 hours after dosing. It is extensively metabolized in the liver to two pharmacologically active metabolites: 2-oxoquazepam and N-desalkyl-2-oxoquazepam (also known as N-desalkylflurazepam). Both metabolites contribute to quazepam's extended duration of action. Quazepam also inhibits the CYP2B6 enzyme, which can raise blood levels of other medications metabolized by this pathway, including bupropion and efavirenz.

The long half-life of quazepam (~40 hours) is both its key therapeutic advantage and its main limitation. It provides durable sleep maintenance throughout the night and reduces rebound insomnia upon discontinuation compared to shorter-acting agents. However, it can accumulate with nightly use, leading to significant next-day sedation, impaired driving ability, and elevated fall risk — particularly in elderly patients.

How Hard Is It to Find Doral (Quazepam) In Stock?

Doral (quazepam) is one of the most difficult sleep medications to find at retail pharmacies in the United States. While it is not on the FDA's official Drug Shortage Database, the branded version has been discontinued and the generic is distributed through a very limited specialty pharmacy network. Most major retail pharmacy chains — including CVS, Walgreens, Rite Aid, Walmart, and Kroger — do not routinely stock quazepam and often cannot order it through their standard wholesale channels.

Sterling Specialty Pharmacy in Mendota Heights, MN (888-618-4126, fax: 866-588-0371, e-scribe #2433693) is the primary fulfillment pharmacy for quazepam and ships nationwide. Independent community pharmacies may be able to special-order it through their wholesalers, though this is not guaranteed. Patients regularly report being unable to fill quazepam at multiple pharmacies without any official shortage notice from the FDA.

If you're struggling to find quazepam at a pharmacy near you, medfinder calls pharmacies near you on your behalf to check which ones can fill your prescription, and texts you the results. This saves you hours of phone calls and helps ensure you can maintain continuous therapy.

Who Can Prescribe Doral (Quazepam)?

As a Schedule IV controlled substance, quazepam can only be prescribed by providers who hold a valid DEA registration. Most licensed physicians, and many nurse practitioners and physician assistants (with appropriate DEA registration and within their scope of practice), are authorized to prescribe Schedule IV substances. Prescribing authority for NPs and PAs varies by state.

• Sleep medicine specialists — Most familiar with quazepam; best option for complex or chronic insomnia
• Psychiatrists — Routinely prescribe benzodiazepines; well-suited for insomnia with psychiatric comorbidities
• Primary care physicians (PCPs) — Can prescribe; may not be familiar with quazepam specifically
• Neurologists — Appropriate for insomnia secondary to neurological conditions
• Nurse practitioners (NPs) and physician assistants (PAs) — Can prescribe in most states when DEA-registered

Telehealth prescribing of quazepam is possible under current DEA rules for Schedule IV substances when there is an established prescriber-patient relationship, though state-specific rules may impose additional requirements. Most patients will need an in-person evaluation initially, with refills potentially manageable via telehealth.

Is Doral (Quazepam) a Controlled Substance?

Yes. Quazepam is classified as a Schedule IV controlled substance under the federal Controlled Substances Act. Schedule IV drugs have accepted medical uses and are considered to have a lower potential for abuse and dependence relative to Schedule I-III substances, but they can still cause physical and psychological dependence.

Practical implications of Schedule IV status for patients include: prescriptions may not be refilled more than 5 times within 6 months from the original prescription date; a new prescription is required after that period. Prescriptions must be written by a DEA-registered provider. Some states have additional restrictions on benzodiazepine prescribing. As a controlled substance, quazepam is subject to stricter pharmacy inventory controls, which is one reason it's harder to find at retail pharmacies that dispense it infrequently.

Quazepam carries the FDA's most serious warning category — a boxed warning — covering three major risk areas: (1) risks from concomitant use with opioids (profound sedation, respiratory depression, coma, death); (2) abuse, misuse, and addiction; and (3) physical dependence and withdrawal reactions, including potentially life-threatening seizures upon abrupt discontinuation after prolonged use.

Common Side Effects of Doral (Quazepam)

Common side effects include:

• Daytime drowsiness and residual hangover effect (most common due to long half-life)
• Dizziness and ataxia (coordination problems)
• Lethargy and fatigue
• Headache
• Dysarthria (slurred speech) at higher doses
• Dry mouth

Serious side effects:

• Respiratory depression (especially when combined with opioids or alcohol)
• Physical and psychological dependence with regular use
• Withdrawal reactions (anxiety, tremors, seizures) upon abrupt discontinuation
• Complex sleep behaviors (sleepwalking, sleep-driving, sleep-eating)
• Anterograde amnesia (memory impairment for events after taking the medication)
• Falls and cognitive impairment (particularly in elderly patients due to drug accumulation)

Final Thoughts on Doral (Quazepam)

Doral (quazepam) is a legitimate, FDA-approved treatment for insomnia with a unique pharmacological profile — notably its selective type 1 benzodiazepine receptor binding and long half-life — that makes it clinically valuable for patients with both sleep-onset and sleep-maintenance insomnia. For the right patient, it offers durable sleep improvement with minimal rebound insomnia compared to shorter-acting agents.

The practical challenge in 2026 is access. The brand Doral has been discontinued, and the generic is primarily available through specialty pharmacies like Sterling Specialty Pharmacy (888-618-4126). Most retail chains don't stock it, and prices without insurance run $655-$900 per 30 tablets. Patients and providers need to plan ahead and work through specialty channels to maintain consistent access.

If you've been prescribed quazepam and are struggling to find a pharmacy that carries it, medfinder can help. We call pharmacies near you to check which ones can fill your quazepam prescription and text you the results — no hours spent on hold required.